DLP printing photocurable chitosan to build bio-constructs for tissue engineering

Tissue engineering requires bioinks that can form stable, biocompatible structures. Prior research has shown that chitosan is a promising material due to its natural origin and biocompatibility. However, a gap remains in adapting chitosan for digital light processing (DLP) printing. Existing methods often struggle with controlling curing times and maintaining structural fidelity. This uncertainty drove the need for a photocurable chitosan formulation suitable for DLP. No prior work had resolved how to graft methacryloyl groups onto chitosan for this purpose. The challenge lies in balancing mechanical properties with biocompatibility. That uncertainty motivated the development of a new bioink. The researchers propose that such a material could enhance the precision of tissue engineering constructs.

This study aimed to develop a photocurable chitosan-based bioink for DLP printing. The specific problem addressed was the lack of a suitable chitosan derivative that could be rapidly and precisely printed into 3D structures. The motivation came from the need for high-resolution, biocompatible scaffolds in tissue engineering. The researchers propose that grafting methacryloyl groups onto chitosan could improve its photocuring properties. The goal was to evaluate how concentration and substitution degree affect the material's performance. The study also sought to confirm biocompatibility after photocuring. The authors suggest that successful DLP printing of chitosan could expand its use in biomedical applications. This approach may offer a new pathway for fabricating complex tissue constructs.

The researchers synthesized CHI-MA by grafting methacryloyl groups onto chitosan. They varied the concentration and substitution degree (DS) of CHI-MA to assess its impact on the material. Rheological tests were conducted to measure the flow behavior of the bioink. Photocuring experiments evaluated how quickly layers could be printed. Mechanical testing assessed the strength of the resulting hydrogels. The team used DLP printing to fabricate 3D structures from the bioink. Cytotoxicity tests were performed to evaluate biocompatibility. The authors propose that these methods could help optimize bioink formulations for tissue engineering applications.

The CHI-MA bioink with a high DS (33.6%) enabled printing of 150 μm thick hydrogel layers in a short time. The material showed favorable rheological properties suitable for DLP printing. Photo-crosslinked gels exhibited good mechanical strength. The curing time was controlled within a reasonable range for practical printing. The bioink formed high-resolution and high-fidelity structures. Cytotoxicity tests confirmed excellent biocompatibility of the printed hydrogels. The printed constructs maintained structural integrity during fabrication. The authors suggest that CHI-MA is a viable bioink for DLP printing in tissue engineering.

The study concludes that CHI-MA is a suitable bioink for DLP printing in tissue engineering. The authors propose that the material's photocuring properties and biocompatibility support its use in biomedical applications. The high DS of CHI-MA allowed for rapid and controlled printing. The printed structures demonstrated structural fidelity and mechanical stability. The researchers suggest that the bioink's performance aligns with the requirements of tissue engineering. The biocompatibility results indicate that the material is safe for cell interaction. The authors propose that this approach could expand the use of chitosan in 3D bioprinting. The findings suggest that CHI-MA could be a valuable tool for fabricating complex tissue constructs.